167 related articles for article (PubMed ID: 31498995)
1. The Effect of Antibody Fragments on CD25 Targeted Regulatory T Cell Near-Infrared Photoimmunotherapy.
Okada R; Maruoka Y; Furusawa A; Inagaki F; Nagaya T; Fujimura D; Choyke PL; Kobayashi H
Bioconjug Chem; 2019 Oct; 30(10):2624-2633. PubMed ID: 31498995
[TBL] [Abstract][Full Text] [Related]
2. Comparison of the Effectiveness of IgG Antibody versus F(ab')
Kato T; Okada R; Furusawa A; Wakiyama H; Furumoto H; Fukushima H; Okuyama S; Choyke PL; Kobayashi H
Mol Pharm; 2022 Oct; 19(10):3600-3611. PubMed ID: 35759343
[TBL] [Abstract][Full Text] [Related]
3. Photoimmunotherapy targeting prostate-specific membrane antigen: are antibody fragments as effective as antibodies?
Watanabe R; Hanaoka H; Sato K; Nagaya T; Harada T; Mitsunaga M; Kim I; Paik CH; Wu AM; Choyke PL; Kobayashi H
J Nucl Med; 2015 Jan; 56(1):140-4. PubMed ID: 25500827
[TBL] [Abstract][Full Text] [Related]
4. Photoimmunotherapy: comparative effectiveness of two monoclonal antibodies targeting the epidermal growth factor receptor.
Sato K; Watanabe R; Hanaoka H; Harada T; Nakajima T; Kim I; Paik CH; Choyke PL; Kobayashi H
Mol Oncol; 2014 May; 8(3):620-32. PubMed ID: 24508062
[TBL] [Abstract][Full Text] [Related]
5. Endoscopic near-infrared photoimmunotherapy in an orthotopic head and neck cancer model.
Okada R; Furusawa A; Inagaki F; Wakiyama H; Kato T; Okuyama S; Furumoto H; Fukushima H; Choyke PL; Kobayashi H
Cancer Sci; 2021 Aug; 112(8):3041-3049. PubMed ID: 34101947
[TBL] [Abstract][Full Text] [Related]
6. Near-infrared photoimmunotherapy (NIR-PIT) of bone metastases.
Inagaki FF; Wakiyama H; Furusawa A; Okada R; Kato T; Fujimura D; Okuyama S; Fukushima H; Takao S; Choyke PL; Kobayashi H
Biomed Pharmacother; 2023 Apr; 160():114390. PubMed ID: 36791566
[TBL] [Abstract][Full Text] [Related]
7. Opening up new VISTAs: V-domain immunoglobulin suppressor of T cell activation (VISTA) targeted near-infrared photoimmunotherapy (NIR-PIT) for enhancing host immunity against cancers.
Wakiyama H; Furusawa A; Okada R; Inagaki F; Kato T; Furumoto H; Fukushima H; Okuyama S; Choyke PL; Kobayashi H
Cancer Immunol Immunother; 2022 Dec; 71(12):2869-2879. PubMed ID: 35445836
[TBL] [Abstract][Full Text] [Related]
8. Real-time monitoring of in vivo acute necrotic cancer cell death induced by near infrared photoimmunotherapy using fluorescence lifetime imaging.
Nakajima T; Sano K; Mitsunaga M; Choyke PL; Kobayashi H
Cancer Res; 2012 Sep; 72(18):4622-8. PubMed ID: 22800710
[TBL] [Abstract][Full Text] [Related]
9. Molecular targeted photoimmunotherapy for HER2-positive human gastric cancer in combination with chemotherapy results in improved treatment outcomes through different cytotoxic mechanisms.
Ito K; Mitsunaga M; Arihiro S; Saruta M; Matsuoka M; Kobayashi H; Tajiri H
BMC Cancer; 2016 Jan; 16():37. PubMed ID: 26810644
[TBL] [Abstract][Full Text] [Related]
10. Near-infrared photoimmunotherapy of cancer: a new approach that kills cancer cells and enhances anti-cancer host immunity.
Kobayashi H; Furusawa A; Rosenberg A; Choyke PL
Int Immunol; 2021 Jan; 33(1):7-15. PubMed ID: 32496557
[TBL] [Abstract][Full Text] [Related]
11. Near-infrared theranostic photoimmunotherapy (PIT): repeated exposure of light enhances the effect of immunoconjugate.
Mitsunaga M; Nakajima T; Sano K; Choyke PL; Kobayashi H
Bioconjug Chem; 2012 Mar; 23(3):604-9. PubMed ID: 22369484
[TBL] [Abstract][Full Text] [Related]
12. Real-time monitoring of microdistribution of antibody-photon absorber conjugates during photoimmunotherapy in vivo.
Tang Q; Nagaya T; Liu Y; Lin J; Sato K; Kobayashi H; Chen Y
J Control Release; 2017 Aug; 260():154-163. PubMed ID: 28601576
[TBL] [Abstract][Full Text] [Related]
13. Near-infrared photoimmunotherapy in the models of hepatocellular carcinomas using cetuximab-IR700.
Takao S; Fukushima H; King AP; Kato T; Furusawa A; Okuyama S; Kano M; Choyke PL; Escorcia FE; Kobayashi H
Cancer Sci; 2023 Dec; 114(12):4654-4663. PubMed ID: 37817415
[TBL] [Abstract][Full Text] [Related]
14. Near infrared photoimmunotherapy targeting DLL3 for small cell lung cancer.
Isobe Y; Sato K; Nishinaga Y; Takahashi K; Taki S; Yasui H; Shimizu M; Endo R; Koike C; Kuramoto N; Yukawa H; Nakamura S; Fukui T; Kawaguchi K; Chen-Yoshikawa TF; Baba Y; Hasegawa Y
EBioMedicine; 2020 Feb; 52():102632. PubMed ID: 31981983
[TBL] [Abstract][Full Text] [Related]
15. Near-infrared photoimmunotherapy and anti-cancer immunity.
Nakajima K; Ogawa M
Int Immunol; 2024 Feb; 36(2):57-64. PubMed ID: 37843836
[TBL] [Abstract][Full Text] [Related]
16. Near infrared photoimmunotherapy targeting bladder cancer with a canine anti-epidermal growth factor receptor (EGFR) antibody.
Nagaya T; Okuyama S; Ogata F; Maruoka Y; Knapp DW; Karagiannis SN; Fazekas-Singer J; Choyke PL; LeBlanc AK; Jensen-Jarolim E; Kobayashi H
Oncotarget; 2018 Apr; 9(27):19026-19038. PubMed ID: 29721181
[TBL] [Abstract][Full Text] [Related]
17. The chemical basis of cytotoxicity of silicon-phthalocyanine-based near infrared photoimmunotherapy (NIR-PIT) and its implications for treatment monitoring.
Kobayashi H; Choyke PL; Ogawa M
Curr Opin Chem Biol; 2023 Jun; 74():102289. PubMed ID: 36966701
[TBL] [Abstract][Full Text] [Related]
18. CD47-Targeted Near-Infrared Photoimmunotherapy for Human Bladder Cancer.
Kiss B; van den Berg NS; Ertsey R; McKenna K; Mach KE; Zhang CA; Volkmer JP; Weissman IL; Rosenthal EL; Liao JC
Clin Cancer Res; 2019 Jun; 25(12):3561-3571. PubMed ID: 30890547
[TBL] [Abstract][Full Text] [Related]
19. Near-infrared photoimmunotherapy targeting PD-L1: Improved efficacy by preconditioning the tumor microenvironment.
Inagaki FF; Kano M; Furusawa A; Kato T; Okada R; Fukushima H; Takao S; Okuyama S; Choyke PL; Kobayashi H
Cancer Sci; 2024 Apr; ():. PubMed ID: 38671582
[TBL] [Abstract][Full Text] [Related]
20. Near infrared photoimmunotherapy for cancers: A translational perspective.
Maruoka Y; Wakiyama H; Choyke PL; Kobayashi H
EBioMedicine; 2021 Aug; 70():103501. PubMed ID: 34332294
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
